Physician profile
Melissa Dowling
NPI 1427764901
$510.17
in general payments reported to CMS, 2019-2025
13 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $116 · 2024: $159 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $100.16 | 2023 | Fisher & Paykel Healthcare |
| Lemaitre Vascular, INC. | $51.63 | 2025 | Restoreflow, Hydro Lemaitre Valvulotome |
| Neuros Medical, INC. | $51.49 | 2025 | Altius |
| Aroa Biosurgery Incorporated | $47.22 | 2024-2025 | |
| Ethicon US, LLC | $47.16 | 2024 | Vistaseal, Evarrest, Surgicel Nu-Knit |
| Ets Wound Care LLC | $46.12 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Acera Surgical, INC. | $37.79 | 2025 | Restrata Wound Matrix |
| Bard Peripheral Vascular, INC. | $29.24 | 2025 | Rotarexs 6 F X 135 Cm |
| Amgen INC. | $27.23 | 2024 | Repatha |
| Terumo Medical Corporation | $22.77 | 2024 | Glidewire |
| Shockwave Medical, INC | $19.51 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $15.47 | 2023 | Xarelto |
| Smith+Nephew, INC. | $14.38 | 2024 | Pico 14, Renasys Touch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Dowling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.